People

Showing 1565 People
Sort by:
  • Aly Beynon

    Aly Beynon

    New York, New York, USA

    Mindbloom

  • Adam Von Reyn

    Adam Von Reyn

    Boston, Massachusetts, USA

    Mindbloom

  • Peter Di Iorio

    Peter Di Iorio

    New York, New York, USA

    Mindbloom

  • Jennifer Holder-Murray
  • Anna Rockich
  • David E. Olson

    David E. Olson

    Davis, California, USA

    University of California, Davis • Delix Therapeutics • Olson Lab

  • Josh Hardman

    Josh Hardman

    Psilocybin Alpha

  • M Winkelman

    M Winkelman

    Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia

  • J Mabit

    J Mabit

    Ayahuasca in the treatment of addictions

  • KB Thor

    KB Thor

    Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N, N-dimethyltryptamine

  • T Hisamitsu

    T Hisamitsu

    Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N, N-dimethyltryptamine

  • WC de Groat

    WC de Groat

    Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N, N-dimethyltryptamine

  • LP Cameron

    LP Cameron

    Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

  • E Rajnavolgyi

    E Rajnavolgyi

    Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 …

  • A Ramirez

    A Ramirez

    Determination of N, N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca

  • HW Shen

    HW Shen

    Psychedelic 5-methoxy-N, N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions

  • XL Jiang

    XL Jiang

    Psychedelic 5-methoxy-N, N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions

  • Brad Burge
  • TP Su

    TP Su

    When the endogenous hallucinogenic trace amine N, N-dimethyltryptamine meets the sigma-1 receptor

  • D Luke

    D Luke

    DISCARNATE ENTITIES AND DIMETHYLTRYPTAMINE (DMT): PSYCHOPHARMACOLOGY, PHENOMENOLOGY AND ONTOLOGY.

  • AR Hajipour

    AR Hajipour

    The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator

  • E Grasa

    E Grasa

    Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant

  • PCR Barbosa

    PCR Barbosa

    Health status of ayahuasca users

  • H Jungaberle

    H Jungaberle

    The internationalization of ayahuasca

  • Patrycja Slawuta